Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
1,379 results
  • Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report. [Case Reports]
  • MMedicine (Baltimore) 2018; 97(37):e12236
  • He Y, He H, … Cheng W
  • CONCLUSIONS: This is the first case reporting the successful use of fondaparinux for full anticoagulation for DVT in a critically ill patient with HIT and renal insufficiency. Our experience suggests that fondaparinux might be an alternative for anticoagulation treatment in patients with HIT and kidney dysfunction if another anticoagulant (argatroban) is unavailable.
  • Heparin-induced thrombocytopaenia. [Review]
  • PMPostgrad Med J 2018; 94(1114):453-457
  • Prince M, Wenham T
  • Heparin-induced thrombocytopaenia (HIT) is a severe and potentially life-threatening adverse drug reaction. Patients become extremely hypercoagulable, and this can lead to life-threatening and limb-t...
  • Argatroban plus aspirin versus aspirin in acute ischemic stroke. [Journal Article]
  • NRNeurol Res 2018; 40(10):862-867
  • Chen L, Cao S, Yang J
  • CONCLUSIONS: Argatroban is effective and safe for the treatment of moderate AIS with similar efficacy to high-dose aspirin in the acute phase of AIS, although no additional benefit on short-term outcome was observed. For patients with mild AIS, argatroban may be inferior to high-dose aspirin.
New Search Next